monday.com is Now Oversold (MNDY)

monday.com (MNDY) traded as low as $126.4125 and registered an RSI of 29.6 on Friday, putting the stock into traditional oversold territory versus the S&P 500 ETF (SPY) RSI of 57.8. The share price sits essentially at its 52-week low ($126.4125) against a 52-week high of $342.64 with a last trade near $126.70, a setup some investors may interpret as a potential entry signal from a technical perspective.

Analysis

Market structure: MNDY’s RSI at ~29.6 and trading at its 52-week low signals capitulation in a high-beta collaboration SaaS name; direct beneficiaries are larger, cash-rich incumbents (TEAM, MSFT) that can consolidate market share if small vendors retrench, while smaller point-solution vendors and late-stage private competitors face more difficult fundraising and pricing pressure. The sell-off compresses valuation multiples across mid-cap SaaS, increasing M&A optionality for acquirers and pressuring smaller competitors’ revenue growth as enterprise buyers postpone large rollout projects (quarters).

Risk assessment: Near-term (days-weeks) the most likely outcomes are a mean-reversion bounce of 5–15% or continuation to test sub-$115 if macro risk-off persists; medium-term (1–3 months) risk centers on subscription churn and renewal cadence around the next earnings cycle, while long-term (3–24 months) risks include competitive displacement and margin erosion from price-led acquisition. Tail risks include a material enterprise customer churn (>5% of ARR) or a failed product pivot that would trigger multiple compression >30%; hidden dependencies include AWS/SaaS infra cost volatility and concentrated customer cohorts.

Trade implications: Tactical long exposure (low-conviction) is justified on technical oversold signals but should be size-limited: consider 2–3% portfolio long positions with 8–12% stop limits and a 6–12 week horizon, or selling puts to improve entry basis; if implied volatility spikes, prefer calendar or diagonal spreads to collect premium. Relative trades: long MNDY vs short ASAN/SMAR if due diligence confirms superior retention/GTN economics; rotate partial proceeds from high-duration SaaS into cheaper, cash-positive enterprise software names.

Contrarian angles: Consensus focuses solely on technical oversold status and ignores that today's valuation may already price in 20–30% ARR contraction scenarios; if renewal cohorts hold, upside of 40–60% becomes plausible over 6–12 months as multiples re-rate. Conversely, the crowd may be underestimating revenue cyclicality in SMEs — a mispriced short could emerge if macro weakens. Historical parallels (post-2022 SaaS troughs) show rapid 30–50% recoveries when macro stabilizes, implying timing sensitivity around macro data and earnings.

Key Decisions for Investors

• Establish a tactical 2–3% portfolio long position in MNDY (buy limit $120–$130) with an initial stop-loss at $110 and a target zone of $150–$180 within 6–12 weeks; trim to reduce to 1% at +15% and take profits at +40–50%.
• If conviction is low but you want exposure, sell 3–6 month MNDY cash-secured puts at the $110 strike to collect premium, size to no more than 2% of portfolio and set a hard assignment limit at $105.
• Construct a directional options spread ahead of earnings: buy 2–3 month at-the-money call debit spread (buy ATM, sell +10–15% OTM) to limit cost and benefit from post-oversold mean reversion; cap premium to 0.5–1% of portfolio value.
• Initiate a pair trade: long MNDY (1.5% portfolio) vs short ASAN or SMAR (0.75% each) over a 3–9 month horizon to express idiosyncratic recovery vs category laggards; exit if relative performance reverses by 10% or if renewal metrics are negative on the next earnings.